Novo Nordisk Adr (NVO)

Jul 27, 2026

Novo Nordisk A/Sshare repurchase programme - Finansavisen

Jul 27, 2026

Jul 25, 2026

ETFs Investing in Novo Nordisk A/S Sponsored ADR Class B Stocks - TradingView

Jul 25, 2026

Jul 24, 2026

Novo Nordisk A/S Sponsored ADR Class B Revenue Breakdown – MUN:NOVA - TradingView

Jul 24, 2026

Jul 24, 2026

Europe’s US-Listed ADRs Edged Higher Late Friday Morning - Finimize

Jul 24, 2026

Jul 24, 2026

Market news - investments.halifax.co.uk

Jul 24, 2026

Jul 24, 2026

2 Top Growth Stocks to Buy Right Now Without Any Hesitation - The Motley Fool

Jul 24, 2026

Jul 22, 2026

BR:N1VO34 Stock Latest News - TipRanks

Jul 22, 2026

Jul 22, 2026

NVO Stock Quote Price and Forecast - CNN

Jul 22, 2026

Jul 22, 2026

Novo Nordisk Sues Eli Lilly Over Alleged Deceptive Weight Loss Drug Advertising - Sahm

Jul 22, 2026

Jul 21, 2026

Novo Nordisk A/S ADR (NVO-N) Stock Price and News - The Globe and Mail

Jul 21, 2026

Jul 21, 2026

Novo Nordisk (NYSE: NVO) reports 24,959,179 shares repurchased in 2026 programme - Stock Titan

Jul 21, 2026

Jul 17, 2026

Novo Nordisk's Steady Innovation in Diabetes and Obesity Have Created a Wide Moat - Morningstar

Jul 17, 2026

Jul 17, 2026

Novo Nordisk (NYSE:NVO) Wins EU Approval For Oral And Higher Dose Wegovy - Sahm

Jul 17, 2026

Jul 16, 2026

Wegovy Pill in EuropeNovo Nordisk Expands Franchise With First European Approval for Oral Weight Loss Drug - Sahm

Jul 16, 2026

Jul 14, 2026

NVOH ETF Profile: Dividends, Returns (AMEX:NVOH) - TradingView

Jul 14, 2026

Jul 12, 2026

Novo Nordisk (NVO) Stock May Be 50% Undervalued Despite Medicare GLP 1 Coverage - Sahm

Jul 12, 2026

Jul 08, 2026

Novo Nordisk (NYSE:NVO) Updates Wegovy Label In Singapore With 21% Weight Loss Data - Sahm

Jul 08, 2026

Jul 06, 2026

Total equity of Novo Nordisk A/S ADR Cert Deposito Arg Repr 0.142857 ADR-B – BCBA:NVOD - TradingView

Jul 06, 2026

Jul 06, 2026

Weekly Recap: NOVO_B MAR buyback and Shares jump after UK Wegovy approval - TradingView

Jul 06, 2026

Jul 04, 2026

Novo Nordisk (NVO) Wins UK Wegovy Pill Approval As Medicare Opens GLP 1 Access - Sahm

Jul 04, 2026

Jul 03, 2026

Novo Nordisk and Hims & Hers agree to partner on obesity drugs - Investing.com Nigeria

Jul 03, 2026

Jul 02, 2026

NVONovo Nordisk ADR Options - Finviz

Jul 02, 2026

Jul 01, 2026

European ADRs Slid In US Trading On Wednesday - Finimize

Jul 01, 2026

Jun 29, 2026

Novo Nordisk holds analyst rating, JPMorgan reiterates Neutral on the shares - Ad-hoc-news.de

Jun 29, 2026

Jun 29, 2026

Novo Nordisk consensus picture, shares backed by strong obesity demand - Ad-hoc-news.de

Jun 29, 2026